Nurse Practitioner, Family · Detroit, MI
NPI
1144836701
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4100 John R St
Detroit, MI, 48201
Phone (800) 527-6266
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,466
27 services
Medicare patients, 2024
14
Average age 69
Drug cost, 2024
$5.0M
720 prescriptions
Company payments, 2025
$7,863
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Danielle Blake prescribed most often to Medicare patients was Imbruvica (Ibrutinib), with 79 prescriptions and refills. In total Danielle Blake wrote 720 Medicare prescriptions that cost $5.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Imbruvica Ibrutinib | 79 | 86 | Under 11 | $1.3M |
| Brukinsa Zanubrutinib | 72 | 72 | 11 | $985K |
| Imatinib Mesylate Generic | 71 | 71 | Under 11 | $14K |
| Bosulif Bosutinib | 51 | 51 | Under 11 | $550K |
| Acyclovir Generic | 45 | 53 | 15 | $744 |
| Calquence Acalabrutinib Maleate | 40 | 40 | Under 11 | $528K |
| Sprycel Dasatinib | 24 | 24 | Under 11 | $238K |
| Venclexta Venetoclax | 22 | 22 | Under 11 | $177K |
| Ciprofloxacin Hcl Generic | 22 | 22 | 11 | $184 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 21 | 21 | Under 11 | $388 |
| Ondansetron Hcl Generic | 20 | 20 | 12 | $69.69 |
| Fluconazole Generic | 19 | 19 | Under 11 | $322 |
| Alprazolam Generic | 18 | 18 | Under 11 | $59.73 |
| Jakafi Ruxolitinib Phosphate | 12 | 12 | Under 11 | $195K |
| Pomalyst Pomalidomide | 12 | 12 | Under 11 | $279K |
Brand drugs: 380 claims; generic drugs: - claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danielle Blake $7,863 ($7,863 in general payments such as food, travel and fees) from 10 companies. The largest payer was GlaxoSmithKline, LLC. with $6,881.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 17 | $6,881 |
| Janssen Biotech, Inc. JNJ | 2 | $214 |
| Pfizer Inc. PFE | 1 | $181 |
| Syndax Pharmaceuticals, Inc. SNDX | 6 | $153 |
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $144 |
| BeiGene USA, Inc. ONC | 1 | $144 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $60.11 |
| BeOne Medicines USA, Inc. ONC | 2 | $39.28 |
| Kite Pharma, Inc. GILD | 1 | $31.76 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $15.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.